Robert J. Scheuplein

5.2k total citations · 5 hit papers
42 papers, 3.9k citations indexed

About

Robert J. Scheuplein is a scholar working on Pharmaceutical Science, Health, Toxicology and Mutagenesis and Dermatology. According to data from OpenAlex, Robert J. Scheuplein has authored 42 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmaceutical Science, 9 papers in Health, Toxicology and Mutagenesis and 7 papers in Dermatology. Recurrent topics in Robert J. Scheuplein's work include Advancements in Transdermal Drug Delivery (13 papers), Carcinogens and Genotoxicity Assessment (6 papers) and Contact Dermatitis and Allergies (6 papers). Robert J. Scheuplein is often cited by papers focused on Advancements in Transdermal Drug Delivery (13 papers), Carcinogens and Genotoxicity Assessment (6 papers) and Contact Dermatitis and Allergies (6 papers). Robert J. Scheuplein collaborates with scholars based in United States, United Kingdom and France. Robert J. Scheuplein's co-authors include Irvin H. Blank, Michael L. Dourson, Gail Charnley, Michael A. Gallo, Linda J. Morgan, P H Dugard, Robert L. Bronaugh, Shotaro Yamaguchi, Atsushi Mizutani and Janet A. Springer and has published in prestigious journals such as Nature, Science and Physiological Reviews.

In The Last Decade

Robert J. Scheuplein

42 papers receiving 3.5k citations

Hit Papers

Permeability of the skin 1965 2026 1985 2005 1971 1967 1965 1969 1967 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Scheuplein United States 20 2.6k 1.8k 555 475 446 42 3.9k
Robert L. Bronaugh United States 32 2.0k 0.8× 1.8k 1.0× 275 0.5× 450 0.9× 387 0.9× 71 3.6k
Irvin H. Blank United States 20 2.4k 0.9× 1.9k 1.1× 491 0.9× 151 0.3× 360 0.8× 40 3.6k
Ronald C. Wester United States 33 1.3k 0.5× 1.4k 0.8× 244 0.4× 489 1.0× 277 0.6× 113 3.4k
Santo Scalia Italy 36 1.1k 0.4× 708 0.4× 530 1.0× 130 0.3× 551 1.2× 131 3.4k
Jens J. Thiele United States 29 294 0.1× 1.9k 1.0× 218 0.4× 286 0.6× 868 1.9× 65 3.7k
Jeanetta du Plessis South Africa 34 1.4k 0.5× 855 0.5× 502 0.9× 41 0.1× 1.0k 2.3× 113 4.1k
Ann‐Therése Karlberg Sweden 38 209 0.1× 3.1k 1.7× 676 1.2× 498 1.0× 590 1.3× 153 4.9k
Sanja Kežić Netherlands 38 806 0.3× 3.5k 1.9× 101 0.2× 264 0.6× 506 1.1× 146 4.7k
Eric Fabian Germany 27 383 0.1× 516 0.3× 152 0.3× 540 1.1× 638 1.4× 88 2.6k
Amnon Sintov Israel 27 926 0.4× 325 0.2× 268 0.5× 36 0.1× 390 0.9× 73 2.2k

Countries citing papers authored by Robert J. Scheuplein

Since Specialization
Citations

This map shows the geographic impact of Robert J. Scheuplein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Scheuplein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Scheuplein more than expected).

Fields of papers citing papers by Robert J. Scheuplein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Scheuplein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Scheuplein. The network helps show where Robert J. Scheuplein may publish in the future.

Co-authorship network of co-authors of Robert J. Scheuplein

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Scheuplein. A scholar is included among the top collaborators of Robert J. Scheuplein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Scheuplein. Robert J. Scheuplein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scheuplein, Robert J.. (2015). Permeability of the Skin: A Review of Major Concepts. Current problems in dermatology. 7. 172–186. 5 indexed citations
2.
Scheuplein, Robert J.. (2013). A Personal View of Skin Permeation (1960-2013). Skin Pharmacology and Physiology. 26(4-6). 199–212. 11 indexed citations
3.
Scheuplein, Robert J., et al.. (2009). Evidence for the Relationship of Calcium to Blood Pressure*. Nutrition Reviews. 54(12). 365–381. 28 indexed citations
4.
Wils, Daniel, et al.. (2008). Safety profile of a food dextrin: Acute oral, 90-day rat feeding and mutagenicity studies. Food and Chemical Toxicology. 46(10). 3254–3261. 5 indexed citations
5.
Scheuplein, Robert J., Atsushi Mizutani, & Shotaro Yamaguchi. (2007). Studies on the non-pathogenicity of Chryseobacterium proteolyticum and on the safety of the enzyme: Protein–glutaminase. Regulatory Toxicology and Pharmacology. 49(2). 79–89. 17 indexed citations
6.
Dourson, Michael L., et al.. (2004). Differential Sensitivity of Children and Adults to Chemical Toxicity. Human and Ecological Risk Assessment An International Journal. 10(1). 21–27. 15 indexed citations
7.
Dourson, Michael L., Gail Charnley, & Robert J. Scheuplein. (2002). Differential Sensitivity of Children and Adults to Chemical Toxicity. Regulatory Toxicology and Pharmacology. 35(3). 448–467. 72 indexed citations
8.
Scheuplein, Robert J., Gail Charnley, & Michael L. Dourson. (2002). Differential Sensitivity of Children and Adults to Chemical Toxicity. Regulatory Toxicology and Pharmacology. 35(3). 429–447. 174 indexed citations
9.
Scheuplein, Robert J.. (2000). Pesticides and Infant Risk: Is There a Need for an Additional Safety Margin?. Regulatory Toxicology and Pharmacology. 31(3). 267–279. 10 indexed citations
10.
Scheuplein, Robert J.. (2000). The FQPA: A Challenge for Science Policy and Pesticide Regulation. Regulatory Toxicology and Pharmacology. 31(3). 248–266. 3 indexed citations
11.
Carrington, Clark D., P. Michael Bolger, & Robert J. Scheuplein. (1996). Risk analysis of dietary lead exposure. Food Additives & Contaminants. 13(1). 61–76. 12 indexed citations
12.
Scheuplein, Robert J. & John C. Bowers. (1995). Dioxin–An Analysis of the Major Human Studies: Comparison with Animal‐Based Cancer Risks. Risk Analysis. 15(3). 319–333. 7 indexed citations
13.
Scheuplein, Robert J.. (1995). Use of ‘secondary mechanism’ in the regulation of carcinogens; A chronology. Cancer Letters. 93(1). 103–112. 1 indexed citations
14.
Scheuplein, Robert J.. (1995). Information needed to support hazard identification and risk assessment of toxic substances. Toxicology Letters. 79(1-3). 23–28. 2 indexed citations
15.
Kodell, Ralph L., et al.. (1994). Point Estimates of Cancer Risk at Low Doses. Risk Analysis. 14(5). 843–850. 9 indexed citations
16.
Scheuplein, Robert J.. (1993). Use of cell proliferation data in cancer risk assessment: FDA view.. Environmental Health Perspectives. 101(suppl 5). 139–141. 8 indexed citations
17.
Grice, H. C., David B. Clayson, W.G. Flamm, et al.. (1986). Possible mechanisms of BHA carcinogenicity from a consideration of its chemical and biological properties. Food and Chemical Toxicology. 24(10-11). 1235–1242. 8 indexed citations
18.
Kornhauser, Andrija, et al.. (1982). An evaluation of skin painting studies as determinants of tumorigenesis potential following skin contact with carcinogens. Regulatory Toxicology and Pharmacology. 2(1). 22–37. 1 indexed citations
19.
Scheuplein, Robert J.. (1968). On the application of rate theory to complex multibarrier flow co-ordinates: Membrane permeability. Journal of Theoretical Biology. 18(1). 72–89. 20 indexed citations
20.
Scheuplein, Robert J.. (1965). Mechanism of Percutaneous Adsorption. Journal of Investigative Dermatology. 45(5). 334–346. 362 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026